Литература к ЧАСТИ 1 «Заболевания»

1. World Health Organization Pneumococcal vaccines.  Weekly Epidemiological Record 2003;  78(14):  110 – 119.
2. Prevenar package insert.
3. Bradshaw D., Bourne D., Nannan N.  What are the leading causes of death among South Africa children?  MRC Policy Brief 2003; 3.  (Unpublished data).
4. Department of Health, Chief Medical Officer.  Preventing meningitis.  7 December 2006.  http://www.dh.gov.uk/AboutUs/MinistersAndDepartmentLeaders/
   ChiefMedicalOfficer/ProgressOnPolicy/Program.  (Accessed:  20 September 2007)
5. Bedford H., de Louvois J., Halket S., Peckham C., Hurley R., Harvey D.  Meningitis in infancy in England and Wales:  follow up at age 5 years.  BMJ 2001;  323:  1 – 5.
6. Levine O.S., Farley M., Harrison L.H.,  Lefkowitz L., McGeer A., Schwartz B.  Risk Factors for Invasive Pneumococcal Disease in Children:  A Population-based Case-Control Study in North America.  Pediatrics 1999;  103(3):  28 – 33.
7. Ispahani P., Slack R.C.B., Donald F.E., Weston V.C., Rutter N.  Twenty years surveillance of invasive pneumococcal disease in Nottingham:  serogroups responsible and implications for immunization.  Arch Dis Child 2004;  89:  757 – 762.
8. Baraff L.J., Lee S.I., Schriger D.L.  Outcomes of bacterial meningitis in children:  a meta-analysis.  Paed Infect Dis J 1993;  12(5):  389 – 394.
9. McIntosh E.D.G.  How many episodes of hospital care might be prevented by widespread uptake of 7-valent pneumococcal conjugate vaccine?  Arch Dis Child 2003;  88:  859 – 861.
10. Givon-Lavi N., Fraser D., Porat N., Dagan R.  Spread of Streptococcus pneumoniae and Antibiotic-Resistant S. pneumoniae from Day-Care Centre Attendees to Their Younger Siblings.  JID 2002; 186: 1608-14.
11. Grant C.C.,  Harnden A.R., Jewell G., Knox K., Peto T. E., Crook D.W.  Invasive pneumococcal disease in Oxford 1985 – 2001:  a retrospective case series.  Arch Dis Child 2003;  88:  712 – 7
12. Wikipedia, the free encyclopedia
13. Djuretic T., Ryan M.J., Miller E., Fairley C.K., Goldblatt D.  Hospital Admissions in Children due to Pneumococcal Pneumonia in England.  J of Inf 1998; 37:  54 – 58.
14. Miller E., Waight P., Efstratiou A., Brisson M., Johnson A., George R.  Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996 – 1998.  Acta Paed Suppl 2000;  435:  11 – 16.
15. Drummond P., Clark J., Wheeler J., Galloway A., Freeman R., Cant A.  Community acquired pneumonia – a prospective UK study.  Arch Dis Child 2000;  83:  408 – 412.
16. Karstaedt A.S., Khoosal M., Crewe-Brown H.H.  Pneumococcal bacteremia during a decade in children in Soweto, South Africa.  Pediatr Infect Dis J 2000;  19(5):  454 – 457.
17. Subcommittee on Management of Sinusitis and Committee on Quality Improvement.  Clinical Practice Guideline:  Management of Sinusitis.  Pediatrics 2001; 108(3):  798 – 808.
18. Eskola J., Kilpi T., Palmu A., et al.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media.  N Engl J Med 2001;  344(6):  403 – 409.
19. Fireman B., Black S.B., Shinefield H.R., Lee J., Lewis E., Ray P.  Impact of the pneumococcal conjugate vaccine on oitits media.  Pediatr Infect Dis J 2003;  22(1):  10 – 16.
20. Kornelisse R.F., Westerbeek C.M.L., Spoor A.B., et al.  Pneumococcal Meningitis in Children:  Prognostic Indicators and Outcome.  Clin Inf Dis 1995;  21:  1390 – 1397.
21. Von Gottberg A.  Respiratory and meningitis pathogens surveillance, South Africa, 2006.  Comm Dis Surveillance Bull 2007;  5(1):  10 – 14.
22. Merck Manual Professional.  http://www.merck.com/mmpe/print/sec14/ch167/ch167g.html
23. Health Encyclopedia – Diseases and Conditions.  http://www.healthscout.com/ency/68/611/main.html